These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33980161)

  • 1. Cost effectiveness of using Faecal Immunochemical Testing (FIT) as an initial diagnostic investigation for patients with lower gastrointestinal symptoms suggestive of malignancy.
    Kearsey CC; Graham C; Lobb HS; Chacko J; Weatherburn R; Rooney PS
    BMC Fam Pract; 2021 May; 22(1):90. PubMed ID: 33980161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study.
    D'Souza N; Delisle TG; Chen M; Benton SC; Abulafi M;
    Br J Surg; 2021 Jul; 108(7):804-810. PubMed ID: 33755051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

  • 5. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
    D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
    Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
    Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
    Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding the needle in the haystack: the diagnostic accuracy of the faecal immunochemical test for colorectal cancer in younger symptomatic patients.
    D'Souza N; Monahan K; Benton SC; Wilde L; Abulafi M;
    Colorectal Dis; 2021 Oct; 23(10):2539-2549. PubMed ID: 34240526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
    Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
    Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
    Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.
    Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J
    Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
    Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
    BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.
    Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M
    Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal Immunochemical Test (FIT) Sensitivity; A Five Year Audit.
    Cole E; Narayanan D; Tiam RN; Shepherd J; Hajjawi MOR
    Br J Biomed Sci; 2024; 81():12862. PubMed ID: 38868754
    [No Abstract]   [Full Text] [Related]  

  • 14. Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway.
    Johnstone MS; Burton P; Kourounis G; Winter J; Crighton E; Mansouri D; Witherspoon P; Smith K; McSorley ST
    Int J Colorectal Dis; 2022 Feb; 37(2):457-466. PubMed ID: 34932152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
    Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
    Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer.
    Turvill JL; Turnock D; Cottingham D; Haritakis M; Jeffery L; Girdwood A; Hearfield T; Mitchell A; Keding A
    Br J Gen Pract; 2021 Aug; 71(709):e643-e651. PubMed ID: 33798091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.
    Pin-Vieito N; Iglesias MJ; Remedios D; Rodríguez-Alonso L; Rodriguez-Moranta F; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Martínez-Bauer E; Campo R; Bujanda L; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Cubiella J; On Behalf Of The Colonpredict Study Investigators
    World J Gastroenterol; 2020 Jan; 26(1):70-85. PubMed ID: 31933515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal immunochemical test (FIT) based prioritisation of new patient symptomatic cases referred for colorectal investigation.
    Falvey J; Stedman CM; Dunn J; Sies C; Levin S
    N Z Med J; 2024 Sep; 137(1602):102-110. PubMed ID: 39236328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.
    Fraser CG
    Surgeon; 2018 Oct; 16(5):302-308. PubMed ID: 29548552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.